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The paramyxovirus P protein is an essential component of the viral RNA polymerase composed of P and L proteins. In this
study, we characterized the physical and functional interactions between P and L proteins using human parainfluenza virus
type 1 (hPIV1) and its counterpart Sendai virus (SV). The hPIV1 P and SV L proteins or the SV P and hPIV1 L proteins formed
complexes detected by anti-P antibodies. Functional analysis using the minigenome SV RNA containing CAT gene indicated
that the hPIV1 P–SV L complex, but not the SV P–hPIV1 L complex, was biologically active. Mutant SV P or hPIV1 P cDNAs,
which do not express C proteins, showed the same phenotype with wild-type P cDNAs, indicating that C proteins are not
responsible for the dysfunction of SV P–hPIV1 L polymerase complex. Using the chimeric hPIV1/SV P cDNAs, we identified
two regions (residues 387–423 and 511–568) on P protein, which are required for the functional interaction with hPIV1 L.
These regions overlap with a previously identified domain for oligomer formation and binding to nucleocapsids. Our results
indicate that in addition to a P–L binding domain, hPIV1 L requires a specific region on P protein to be biologically functional
as a polymerase. © 2001 Academic Press
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FINTRODUCTION
The Paramyxoviridae is a family of viruses that contain
a single-stranded RNA genome encapsidated by a pro-
tein designated NP into a ribonuclease-resistant ribonu-
cleoprotein complex called the nucleocapsid. The nu-
cleocapsid serves as a template for transcription and
replication of the genome. The NP protein is predicted to
be associated with precisely six nucleotides of viral
genome RNA (Egelman et al., 1989), and some of the
paramyxovirus genomes are efficiently replicated only
when they are a multiple of six nucleotides in length, a
feature known as “the rule of six” (Calain and Roux, 1993).
The phospho- (P) protein and the large (L) protein form
the viral RNA polymerase complex that transcribes and
replicates NP-RNA templates (nucleocapsid) (Hamagu-
chi et al., 1983; Marx et al., 1974; Stone et al., 1972; Lamb
and Kolakofsky, 1996). The P–L polymerase complex
binds to the nucleocapsid through a domain of the P
protein (Portner et al., 1988; Ryan and Portner, 1990; Ryan
t al., 1991).
The P proteins of the respiroviruses human parainflu-
nza virus type 1 (hPIV1) and Sendai virus (SV) are highly
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306hosphorylated and consist of 568 amino acids (Power
t al., 1992). The SV P protein forms a homooligomer via
predicted coiled coil at residues 344–411 (Curran et al.,
995), and a recent study revealed that the SV P protein
orms a tetramer (Tarbouriech et al., 2000a,b). The func-
tional interaction between P and L proteins is not well
understood; however, the L binding site of the SV P
protein has been mapped to a C-terminal region encom-
passing amino acids 413–445 (Curran et al., 1994; Small-
wood et al., 1994), which are located between the pre-
dicted coiled coil and the nucleocapsid binding sites
(Ryan and Portner, 1990; Ryan et al., 1991).
Multiple proteins are produced from different reading
frames of the paramyxovirus P gene. The SV P gene
encodes the P protein, a nested set of C proteins (C9, C,
Y1, and Y2), and the V protein (Curran and Kolakofsky,
1990; Gupta and Patwardhan, 1988). The hPIV1 P gene
also encodes P and C proteins but not a V protein
(Matsuoka et al., 1991; Power et al., 1992). The SV C
roteins appear to bind to the L protein and inhibit viral
NA synthesis (Boeck et al., 1992; Curran et al., 1992;
orikami et al., 1997) in a promoter-specific fashion
Cadd et al., 1996). The replication of mutant SV that was
recovered from cDNA by reverse genetics and does not
express C proteins was severely attenuated in tissue
culture; the C proteins were indispensable for SV multi-
plication and pathogenesis in mice (Kurotani et al., 1998).
urther characterization of the C protein-deficient SV
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307REGIONS OF P REQUIRED FOR INTERACTION WITH Lrevealed that C proteins are required in the SV assembly
process (Hasan et al., 2000).
The L protein has a molecular weight greater than 200
kDa and is the least abundant of the structural proteins
(approximately 40 copies per virion) (Lamb et al., 1976).
The precise composition of the L–P polymerase complex
is unclear, but in vitro this complex can make mRNA that
is both capped at its 59 end and polyadenylated at its 39
end. Like the L protein of vesicular stomatitis virus, the L
proteins of the paramyxoviruses are thought to execute
all of the catalytic steps of RNA synthesis, capping, and
methylation (Wagner and Rose, 1996). The P binding site
has been mapped to the N-terminal 1247 or 1146 amino
acids of the L protein of simian virus 5 or SV, respectively
(Parks, 1994; Chandrika et al., 1995) and the first 408
amino acids of the L protein of measles virus (Horikami
et al., 1994). The comparisons of the amino acid se-
quences of L proteins have revealed six conserved re-
gions (Poch et al., 1990; Sidhu et al., 1993) that are
thought to be essential for the activity of L proteins.
To characterize the transcription and replication of the
respirovirus genome, investigators have used an artifi-
cial genome (pSend-CAT) in which the coding regions of
SV have been replaced with a chloramphenicol acetyl-
transferase (CAT) reporter gene (Park et al., 1991). Cells
infected with SV and transfected with negative-strand
RNA synthesized in vitro from pSend-CAT produce CAT
protein, and the synthetic RNA is packaged into infec-
tious virus. Curran and Kolakofsky (1991) showed that
hPIV1 can drive the intracellular replication of SV-specific
RNA. The SV NP, P, and L proteins expressed from
cDNAs by a vaccinia-T7 expression system support rep-
lication of SV-defective interfering (DI) genomes (Calain
et al., 1992), a finding indicating that these proteins are
sufficient for viral RNA replication.
We cloned the hPIV1 L gene from which functional L
proteins are produced in transfected cells (Takimoto et
al., 2000). In the study described here, interactions be-
tween P and L proteins were characterized by using the
closely related viruses SV and hPIV1. We found that a
polymerase complex composed of the SV P and hPIV1 L
proteins was not biologically functional. Analysis of chi-
meric P constructs revealed two regions of the P protein
required to be functional with hPIV1 L; both regions are
located near the C-terminus of the protein.
RESULTS
Formation of heterologous polymerase complexes
comprising hPIV1 and SV P and L proteins
We previously reported the cloning of the hPIV1 L gene
and expression of the hPIV1 L protein, which forms a
biologically functional complex with the hPIV1 P protein
(Takimoto et al., 2000). The hPIV1 and SV L proteins are
highly similar (86% identity), whereas P proteins are less
conserved (53% identity) (Matsuoka et al., 1991; Takimoto pet al., 2000). To characterize the protein–protein interac-
tion(s) between P and L proteins of type 1 parainfluenza
viruses, we determined whether hPIV1 and SV P and L
proteins could form heterologous polymerase com-
plexes. Because antibodies to L proteins were not avail-
able, P and L proteins were coexpressed in transfected
cells, and the polymerase complexes in cell lysates were
immunoprecipitated with anti-P monoclonal antibodies
(Mabs). When coexpressed with the SV P protein, the
hPIV1 L protein was coimmunoprecipitated with an
anti-SV P Mab (Fig. 1, lane 11). The SV L protein ex-
pressed together with the hPIV1 P protein also formed
heterologous hPIV1 P–SV L polymerase complexes (lane
5). These findings show that the regions of the L and P
proteins required for complex formation are conserved in
these closely related viruses. Although the homology of
the P proteins from these two viruses is not very high, the
region that is conserved in these two proteins is sug-
gested to be involved in the formation of the P–L com-
plex.
Biological activity of heterologous polymerase
complexes
We next examined whether these heterologous P–L
polymerase complexes were biologically active by using
the SV minigenome system (Park et al., 1991). RNA en-
coding a CAT gene flanked by the end sequences of SV
genome was synthesized from cDNA in vitro, and 1 mg of
he purified RNA was transfected into vTF7–3-infected
ells together with pTF1-hNP or pTF1-SVNP (1 mg),
FIG. 1. Formation of complexes by P and L proteins expressed from
cDNAs in cultured cells. HeLa T41 cells were infected with vTF7–3 and
ransfected with plasmids containing L or P genes of hPIV1 or SV. Cells
ere labeled with [35S]-Trans-Label, and proteins from the cell lysates
ere immunoprecipitated with anti-hPIV1 P (lanes 1–5) or anti-SV P
lanes 7–11) Mabs and analyzed by sodium dodecyl sulfate–polyacryl-
mide gel electrophoresis (SDS–PAGE). Lysates were from cells trans-
ected with pTF1-hP (lane 1), pTF1-hL (lanes 2 and 9), pGEM-SVL (lanes
and 8), pTF1-hP and pTF1-hL (lane 4), pTF1-hP and pGEM-SVL (lane
), pTF1-SVP and pGEM-SVL (lane 10), and pTF1-SVP and pTF1-hL
lane 11). Lane 6 contained purified SV. In pTF1-hP-transfected cell
ysates, two hPIV1 P proteins were produced from two separate ATG
odon (nucleotides 8–10 and 104–106), which is in the same reading
rame (Takimoto et al., 2000).TF1-hP or pTF1-SVP (1 mg), and pTF1-hL or pGEM-SVL
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308 BOUSSE ET AL.(0.1 mg). Two days after transfection, CAT activities in the
ell lysates were measured (Fig. 2). CAT activity was
etected in lysates of cells that coexpressed hPIV1 NP, P,
nd L proteins (lane 2). This result indicates that the
PIV1 P–L complex recognized the SV transcription ini-
iation and termination signals to produce functional CAT
ranscripts, a result that we have previously reported
Takimoto et al., 2000). In the absence of pTF1-hL, no
AT activity was detected (lane 1). The activities of hPIV1
–L complexes were, however, about one-third of that of
V P-L complexes (lanes 7 and 10). This may be due to
he use of SV-CAT minigenome or SV polymerase com-
lex itself is more active than that of hPIV1. Cells ex-
ressing the hPIV1 P–SV L complexes displayed CAT
ctivity regardless of the origin of NP (lane 3 and 9)
owever, no CAT activity was detected when SV P and
PIV1 L were expressed with either hPIV1 or SV NP
lanes 4 and 8).
Because the polymerase complex composed of hPIV1
and SV P was not functional, we analyzed the formation
f nucleocapsids composed of heterologous NP, P, and L
roteins. Cells were infected with vTF7–3 and trans-
ected with various combinations of expression vectors
ontaining NP, P, and L genes of SV or hPIV1 under the
ame conditions used for the CAT assay. Nucleocapsids
n the cytoplasm were purified and subjected to sodium
odecyl sulfate–polyacrylamide gel electrophoresis
SDS–PAGE) and analyzed with a PhosphoImager as
escribed under Materials and Methods. The ratio of NP,
, and L proteins that composed the hPIV1 nucleocap-
ids isolated from hPIV1-infected cells was 72:25:3 (Fig.
, lane 6). A similar ratio was observed for nucleocapsids
omposed of hPIV1 NP, P, and L proteins expressed from
FIG. 2. Biological activity of polymerase complexes composed of SV
and hPIV1 proteins. Various combinations of NP, P, and L proteins of
hPIV1 or SV were expressed from cloned genes by the vaccinia-T7
system in HeLa T41 cells that were transfected with pSend-CAT RNA
synthesized in vitro. CAT activities of cell lysates were visualized by
thin-layer chromatography and autoradiography and quantified by us-
ing the PhosphoImager. The origin of NP, P, and L cDNAs is indicated
by the letters h (hPIV1) and S (SV). The sign 2 indicates that the
plasmid was not included in that particular set of transfections.DNAs (lane 1). Nucleocapsids isolated from cells trans-ected with heterologous NP, P, and L proteins also
howed similar ratios of protein composition (lanes 2
hrough 4). The ratio of hPIV1 NP, SV P, and hPIV1 L
roteins in the biologically inactive nucleocapsids was
imilar to that of proteins in the nucleocapsids from
PIV1-infected cells (66:32:2). These findings indicate
hat a polymerase complex was formed in cells express-
ng SV P and hPIV1 L, although it was not biologically
ctive. In addition to the physical binding of P and L,
ther factors may be required for the function of the RNA
olymerase.
he role of C proteins in the dysfunction of the SV
–hPIV1 L complex
The parainfluenza virus P gene encodes, in addition to
he P protein, a nested set of C proteins. The ORF of the
V P gene begins at nucleotide 104; the ORF of the C9
rotein begins at nucleotide 81, and the ORF of the C
rotein begins at nucleotide 114. The ORF of hPIV1 P
egins at nucleotide 104, whereas that of hPIV1 C starts
t nucleotide 114. The SV C protein binds to the L protein
FIG. 3. Ratios of NP, P, and L proteins that compose nucleocapsids
in cells. HeLa T41 cells were infected with vTF7–3 and transfected with
1 mg of pTF1-hNP or pTF1-SVNP, 1 mg of pTF1-hP or pTF1–SVP, and 0.1
mg of pTF1-hL or pGEM-SVL. Nucleocapsids in cells were isolated,
purified, and analyzed by SDS–PAGE. The relative amounts of proteins
in the gels were quantified by using the PhosphoImager. Total radio-
activity of each protein was used to calculate the ratios of NP, P, and L
proteins. Lane 6 shows nucleocapsid proteins isolated from hPIV1-
infected cells. The origin of NP, P, and L cDNAs is indicated as the
letters h (hPIV1) and S (SV). The sign 2 indicates that the plasmid was
not included in that particular set of transfections.
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309REGIONS OF P REQUIRED FOR INTERACTION WITH Land reportedly inhibits viral RNA synthesis (Boeck et al.,
1992; Cadd et al., 1996; Curran et al., 1992; Horikami et
al., 1997); these findings suggest that the C protein is
involved in the polymerase activity of the P–L complex.
To determine whether the C protein is involved in the
function of the heterologous SV and hPIV1 P–L complexes,
we constructed mutant hPIV1 and SV cDNAs from which P
but not C proteins are expressed. We confirmed the ab-
sence of C proteins by coexpressing the mutant P genes
with L genes and immunoprecipitating the polymerase
complex with anti-P Mabs. As shown in Fig. 4A, no C
proteins were bound to the mutant P–L polymerase com-
plex (lanes 3 and 7). We next transfected cells with the
mutant SV P expression plasmids, hPIV1 NP and L expres-
sion plasmids, and pSend-CAT RNA to determine whether
C proteins affect the function of the SV P–hPIV1 L polymer-
ase complex. No CAT activity was detected in cells con-
taining the SV P–hPIV1 L complex, either in the presence or
in the absence of C protein (Fig. 4B, lanes 3 and 4). Cells
expressing hPIV1 P and L proteins displayed CAT activity in
the presence or absence of C protein. These results indi-
cate that the C protein is not required for transcription of SV
minigenome RNA and that the C protein did not cause the
dysfunction of the SV P–hPIV1 L complex.
Identification of the domain of P protein required for
its functional interaction with hPIV1 L
Because C proteins are not involved in the specific
FIG. 4. (A) Expression of C proteins from plasmids containing wild
ransfected with plasmids containing wild-type or mutant P genes and
35S]-Trans-Label. Proteins from the cell lysates were immunoprecipitat
y SDS–PAGE. Lysates were obtained from cells transfected with pGE
ransfected with pTF1-hL and either pTF1hP (lane 6) or pTF1hP(C2) (la
ad been immunoprecipitated with the anti-P Mabs. Lane 1 contains
recipitated proteins from purified hPIV1. (B) Role of C proteins in the
nd L proteins of hPIV1 or SV were expressed from cloned genes as d
hromatography and autoradiography. The origin of NP, P, and L cDNA
re indicated h(C2); those of SV are indicated by S(C2).functional interaction between the SV P and hPIV1 Lproteins, we next determined which regions of the P
protein are responsible for their functional interaction.
We constructed a series of plasmids containing cDNAs
that express chimeric SV-hPIV1 P proteins (Fig. 5A), and
we measured the CAT activity in pSend-CAT RNA-trans-
fected cells that coexpressed hPIV1 NP and L proteins of
SV or hPIV1 (Figs. 5B and 5C). Chimeras CP1 through
CP5 contained the N-terminal 232, 326, 385, 423, and 471
residues of SV P, respectively; the remainder of these
chimeras were derived from hPIV1 P. The levels of CAT
activity in cells expressing CP1, CP2, or CP3 were almost
the same as those of cells expressing hPIV1 P; these
three chimeric proteins were functional with hPIV1 and
SV L proteins. CP4 and CP5 were functional with SV L but
were much less active with hPIV1 L: the level of CAT
activity in cells expressing CP4 and hPIV1 L was 11% of
that in cells expressing hPIV1 P and L; the level of CAT
activity in cells expressing CP5 and hPIV1 L was only 4%
of that in cells expressing hPIV1 P and L. These results
suggest that the interaction between the P and L pro-
teins is responsible for the dysfunction of the SV P–hPIV1
L polymerase complex and that residues 386–423 of
hPIV1 P are required for the chimeric P protein to be
functional with the hPIV1 L protein. However, the chimera
CP6, in which residues 386–423 of the SV P protein were
replaced with those of hPIV1 P, showed little activity in
combination with hPIV1 L; this finding indicates that
these residues are not sufficient to be functional with
nd mutant P cDNAs. HeLa T41 cells were infected with vTF7–3 and
asmids encoding the L genes of hPIV1 or SV. Cells were labeled with
Mab to SV P (lanes 2 and 3) or hPIV1 P (lanes 6 and 7) and analyzed
and either pTF1SVP (lane 2) or pTF1SVP(C2) (lane 3) and from cells
ane 4 represents proteins from the mock-transfected cell lysates that
oprecipitated proteins from purified SV, and lane 5 contains immuno-
al activity of the polymerase complex. Various combinations of NP, P,
ed in Fig. 2. CAT activities of cell lysates were visualized by thin-layer
icated by the letters h (hPIV1) and S (SV). C deletion mutants of hPIV1-type a
with pl
ed with
M-SVL
ne 7). L
immun
biologic
escrib
s is indhPIV1 L.
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311REGIONS OF P REQUIRED FOR INTERACTION WITH LTwo noncontiguous regions of the P protein (amino
acids 345 through 412 and 479 through 568) are required
for binding to the nucleocapsid (Ryan and Portner, 1990;
Ryan et al., 1991). We therefore constructed expression
plasmids containing cDNAs that encode chimeric P pro-
teins containing portions of the C-terminal domain from
hPIV1 P and amino acids 386–423 (Fig. 5A). CP7, which
contained residues 327–423 and 511–568 of hPIV1 P, and
CP8, which contained residues 386–423 and 511–568 of
hPIV1 P, formed functional polymerase complexes with
hPIV1 L (Figs. 5B and 5C). The level of CAT activity was
slightly reduced in cells expressing hPIV1 L and CP9,
which contained amino acids 386–401 and 511–568 of
hPIV1 P. CP10, which contained residues 386–401 and
534–568 of hPIV P, was not functional with hPIV1 L. All of
the chimeric P proteins were active with SV L protein
(Figs. 5B and 5C). These results indicate that two regions
of the P protein, residues 386–423 and 511–568, are
required for functional interaction with hPIV1 L.
One of the regions (residues 386–423) of the P protein
overlaps the predicted coiled-coil area responsible for
oligomer formation (Tabouriech et al., 2000b), which was
suggested to be important for the function of the P
protein (Curran, 1998). Therefore, we determined the
oligomerization states of SV P, hPIV1 P, CP7 (a chimeric
P protein that formed a functional polymerase with hPIV1
L), and CP10 (a chimeric P protein that was unable to
form a functional polymerase with hPIV1 L). Oligomeriza-
tion of P proteins was characterized by sedimentation on
glycerol gradients (Curran et al., 1995). All of the P pro-
teins showed similar sedimentation profiles: a large
peak in fraction 6 was observed as previously reported
for SV P proteins expressed in mammalian cells (Fig. 6)
(Curran et al., 1995; Curran, 1998; Smallwood et al., 1994).
We did not detect a significant difference in oligomer
formation between the P proteins that were functional
with hPIV1 L protein and those that were not.
DISCUSSION
Although the L protein is believed to perform all of the
enzymatic processes associated with transcription and
replication (i.e., initiation, elongation, termination of ribo-
nucleotide polymerization, capping, polyadenylation of
mRNA transcripts, and methylation) (Banerjee, 1987; Ga-
linsky, 1991), the P protein is essential for the function of
paramyxovirus polymerase. In this study, we analyzed
the protein–protein interaction involved in the viral tran-
scription and replication process by using the closely
related viruses SV and hPIV1. Although most of the SV
and hPIV1 proteins are highly homologous, the P protein
FIG. 5. Characterization of chimeric P proteins. (A) Schematic diag
transfected with chimeric P genes together with hPIV1 NP and hPIV1 o
above the lanes in (B), and those of P and L cDNAs are below and to the rigis the least conserved (53% identity) among the structural
proteins of these viruses (Matsuoka et al., 1991). The SV
polymerase complex (SV P–SV L) was functional with the
hPIV1 NP protein, and the hPIV1 polymerase complex
was functional with the SV NP protein (Fig. 2, lanes 5 and
10); these findings suggest that the domains of the P
protein that bind to nucleocapsids are conserved. Stud-
ies using deletion mutants have revealed that the nu-
cleocapsid binding domain of the SV P protein is com-
posed of two separate regions, amino acids 345–412 and
amino acids 479–568 (Fig. 7) (Ryan and Portner, 1990;
Ryan et al., 1991). Therefore, it is suggested that the
conserved residues in these regions are responsible for
the binding of P to the nucleocapsid. In addition to the
nucleocapsid binding site, the L binding site is also
conserved in SV and hPIV1 P proteins; this fact is sup-
ported by our finding that P and L proteins of these
viruses formed heterologous polymerase complexes
(Fig. 1). It was previously reported that a region encom-
passing amino acids 413–445 of the SV P protein is
responsible for binding to the L protein (Curran et al.,
1994; Smallwood et al., 1994). The hPIV1 and SV P pro-
teins are well conserved in this region (74% identity);
residues 413–438 share 92% identity. The high homology
of P proteins in this region is in agreement with our
finding that P and L proteins of SV and hPIV1 form
heterologous P–L complexes.
Coexpression of P and L proteins of hPIV1 and SV
revealed that the hPIV1 L protein could form complexes
with SV P. However, this heterologous P–L complex was
not biologically active. Cells expressing SV P-hPIV1 L
complex were unable to produce CAT from pSend-CAT
RNA regardless of the origin of coexpressed NP (Fig. 2,
lanes 4 and 8). We do not know whether the lack of CAT
activity was due to the failure of RNA replication or
transcription or both. A possible explanation for the lack
FIG. 6. Sedimentation analysis of P proteins. SV P, hPIV1 P, CP7, and
CP10 were expressed in HeLa T41 cells, and extracts of these cells
ere centrifuged on 5–20% glycerol gradients as described under
aterial and Methods. Ten fractions were collected. The P protein in
ach fraction was immunoprecipitated with anti-P Mabs, and the pre-
ipitated proteins were analyzed by SDS–PAGE.
chimeric P proteins. (B) and (C) CAT expression in lysates of cells
cDNAs as described in Fig. 2. The origins of the P cDNAs are shownram of
r SV Lht of the bars in (C).
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312 BOUSSE ET AL.of the function is that additional proteins encoded by the
SV P gene (i.e., C proteins) inhibit the activity of hPIV1 L.
The SV C protein binds to the L protein and reportedly
inhibits viral RNA synthesis (Boeck et al., 1992; Curran et
al., 1992; Horikami et al., 1997) in a promoter-specific
fashion (Cadd et al., 1996); this binding and inhibition
suggest that C proteins regulate the polymerase activity
of the P–L complex. Because the overall sequence ho-
mologies of the hPIV1 and SV C proteins are relatively
high (70%), the SV C proteins may strongly inhibit the
function of hPIV1 L. However, our results with the SV
P(C2) expression plasmid that does not express C and
C9 proteins do not support the possibility that SV C, C9, or
both inhibit the function of the SV P–hPIV1 L complex.
Another possible explanation for the lack of functional
transcripts produced by the SV P–hPIV1 L complex is
that the hPIV1 L protein requires its own C protein to be
functional. However, this possibility is also not supported
by our results: we found that CAT activities were de-
tected in cells transfected with hP(C2) and hL cDNAs
(Fig. 4B).
The heterologous polymerase complex composed of
SV L and hPIV1 P was biologically functional, while the
other heterologous combination of hPIV1 L and SV P was
not, regardless of the NP origin. This suggests that the
domains on P protein that are involved in the functional
interaction with SV L are conserved, while hPIV1L-SV P
interaction requires greater specificity to be biologically
active. The results of the SV-hPIV1 chimeric P constructs
indicate that hPIV1 L protein required two separate re-
FIG. 7. Sequence comparison of the C-terminal regions of the P
proteins of hPIV1 and SV. The regions required for the functional
interaction with hPIV1 L identified in this study are highlighted in light
gray. The putative coiled-coil domain (Tabouriech et al., 2000b) is
indicated by the asterisk (*); the L binding domain (Curran et al., 1994;
Smallwood et al., 1994), by the pound sign (#); and the NP binding
domain (Ryan et al., 1991), by the caret (^).gions on P protein (amino acids 386–423 and 511–568)derived from hPIV1 P to be biologically active. These two
regions overlap regions A (amino acids 345–412) and C
(amino acids 479–568), both of which are necessary for
the stable binding to the nucleocapsid (Fig. 7). Therefore,
at least for hPIV1 polymerase complex, the precise in-
teraction between NP-RNA and P–L complex might be
necessary for its polymerase activity. It has been pro-
posed that P or P–L complex cartwheel over the NP-RNA
template (Curran, 1998), opening the NP-RNA structure
so that the polymerase can interact with viral RNA in the
nucleocapsid. The interaction of polymerase complex
with nucleocapsid is a prerequisite for the proper access
to viral RNA and the failure to contact precisely to the
nucleocapsid could result in the failure of the transcrip-
tion and replication of the genome.
Recently, oligomerization domain of SV P protein was
crystallized and its X-ray structure was revealed (Tabou-
riech et al., 2000b). Residues 364–428 form a long helix
structure that is responsible for the tetramer formation of
the P protein. One of the two regions on P protein (amino
acids 386–423) required to generate a functional P–L
complex of hPIV1 is within the long helix structure. This
helix is also includes the L binding site (Bowman et al.,
999) and is required for the stable binding to the NP-
NA. These results may suggest that the helix region
nd probably the oligomer structure are important for the
unctional interaction with L protein and the access to
iral RNA in nucleocapsid. Future analysis of P structure
hould further our understanding of the mechanism of
–L transcription and replication of the paramyxovirus
NA genome.
MATERIALS AND METHODS
iruses and cells
Recombinant vaccinia virus vTF7–3 (Fuerst et al., 1986)
as grown in TK1 cells. HeLa T41 cells were maintained
in Dulbecco’s modified Eagle’s medium with 5% fetal
bovine serum.
cDNA synthesis and cloning
The construction of pTF1-hNP, pTF1-hP, pTF1-hL,
pTF1-SVNP, and pTF1-SVP has been described else-
where (Takimoto et al., 2000). The plasmid pGEM-SVL,
which contained the SV L gene in pGEM, was a kind gift
from K. C. Gupta, Rush-Presbyterian-St. Luke’s Medical
Center, Chicago, IL. The plasmid pSend-CAT (Park et al.,
1991) was kindly provided by M. Krystal, Mount Sinai
School of Medicine, New York, NY. The pTF1hP(C2) and
pTF1SVP(C2) plasmids were constructed by using the
Transformer site-directed mutagenesis kit (Clontech, Palo
Alto, CA). The primer used to insert a stop codon after the
start codon of the C ORF in the hPIV1 P gene was
GATCAGGATGCCTTCTTTTTAGAGAGGGATCCTGAAGCCG;
the primer used to insert a stop codon after the start codon of
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313REGIONS OF P REQUIRED FOR INTERACTION WITH Lthe C ORF in the SV P gene was GATCAAGATGCCTTCAT-
TCTAAAAGAAGATTCTGAAGTTG. Chimeric hPIV1-SV P
DNAs were constructed by using PCR and overlap extension
o splice the genes together (Horton et al., 1989).
Immunoprecipitation of the expressed proteins
HeLa T41 cells in six-well culture plates were infected
ith the recombinant vaccinia virus vTF7–3 that ex-
resses T7 RNA polymerase at a multiplicity of infection
f 3 and transfected with 2 mg of expression vectors
ncoding L or P genes or both by LipofectAMINE (Life
echnologies, Grand Island, NY). Cells were cultured
vernight and then labeled with 100 mCi of [35S]-Trans-
abel (ICN, Costa Mesa, CA) for 4 h. Labeled cells were
ashed and lysed with 1 ml of TNE buffer (10 mM Tris,
H 7.4; 150 mM NaCl; 0.5% NP-40; and 1 mM EDTA). The
ysates were clarified by centrifugation at 15,000 g for 10
in, and the supernatants were used for immunoprecipi-
ation. Two microliters of anti-hPIV1 or SV P Mabs was
ncubated with 20 ml Dynabeads (Dynal, Lake Success,
Y) in TNE buffer at 4°C for 30 min and washed with the
ame buffer. The Mab–Dynabead complexes were incu-
ated with 100 ml of cell lysate in TNE buffer at 4°C for
30 min. The immunocomplexes were washed with TNE
buffer and analyzed by SDS–PAGE.
In vitro transcription, transfection, and CAT assays
Run-off transcription of EarI-digested pSend-CAT was
performed with the MEGAscript transcription kit (Am-
bion, Austin, TX). The transcripts were purified by purifi-
cation column (Qiagen, Valencia, CA), and the yield of
transcripts was quantified by comparing their intensity
with that of standard RNAs after electrophoresis in a 1%
agarose gel and after staining with ethidium bromide.
Approximately 1 mg of RNA was transfected into vTF7–
3-infected HeLa T41 cells together with 1 mg of pTF1-
NP or pTF1-SVNP, 1 mg of pTF1-hP or pTF1-SVP, and 0.1
mg of pTF1-hL or pGEM-SVL. Each transfection was
done with 8 ml of LipofectAMINE (Life Technologies).
AT assays were performed 48 h after transfection as
nstructed by the manufacturer (Promega, Madison, WI).
cetylation was visualized by thin-layer chromatography
nd autoradiography and quantified by using the Phos-
hoImager (Molecular Dynamics, Piscataway, NJ).
urification of nucleocapsids
Semi-confluent HeLa T41 cells in six-well plates were
nfected with vTF7–3 and transfected with the pTF1 or
GEM plasmids containing NP, P, and L genes as de-
cribed above. Twenty-four hours after infection, cells
ere labeled with 100 mCi of [35S]-Trans-Label (ICN) for
4 h and lysed with 1 ml of TNE buffer. The nucleocapsids
in the clarified supernatants were purified by glycerol-
sucrose step-gradient centrifugation as described previ-
ously (Deshpande and Portner, 1984). Purified nucleo-capsids collected from the interface were suspended in
phosphate-buffered saline (PBS) and concentrated by
centrifugation at 150,000 g for 1 h at 4°C in an SW55 rotor
(Beckman, Fullerton, CA). The pellets were suspended in
Laemmli sample buffer and analyzed by SDS–PAGE. The
relative amounts of NP, P, and L proteins in the gel were
quantified by using the PhosphoImager (Molecular Dy-
namics).
Glycerol gradient analysis
Sedimentation analysis of the P proteins was per-
formed as described previously (Curran et al., 1995;
Horikami et al., 1992). Briefly, semi-confluent HeLa T41
cells were infected with vTF7–3 and transfected with
pTF1-hP or pTF1-SVP. Twenty-four hours after infection,
the cells were labeled with 100 mCi of [35S]-Trans-Label
(ICN) for 4 h. The cells were rinsed with ice-cold PBS and
incubated with Buffer A [ 5% sucrose, 80 mM KCl, 35 mM
HEPES (pH 7.4), 5 mM K2PO4, 5 mM MgCl2, and 0.5 mM
aCl2] containing 0.1% Triton X-100. After Buffer A was
emoved, the cells were scraped, suspended in RM salts
100 mM HEPES (pH 8.5), 150 mM NH4Cl, 4.5 mM
agnesium acetate, and 1 mM dithiothreitol], and dis-
upted by pipetting. After spinning at 12,000 g for 5 min at
°C, the extracts were layered over 5–20% glycerol gra-
ients in RM salts. Gradients were centrifuged in an
W55 rotor at 200,000 g for 19 h at 4°C. Ten fractions
volume of each fraction, 500 ml) were collected from the
top of the tube and subjected to immunoprecipitation.
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